ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4 | 0.0% | 70 | 0.0% | 0.00% | – |
Q2 2023 | $4 | +33.3% | 70 | 0.0% | 0.00% | – |
Q1 2023 | $3 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2022 | $3 | -99.7% | 70 | +159.3% | 0.00% | – |
Q3 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
Q2 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
Q1 2021 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
Q4 2020 | $1,000 | -50.0% | 27 | -60.3% | 0.00% | – |
Q3 2020 | $2,000 | -33.3% | 68 | 0.0% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 68 | 0.0% | 0.00% | – |
Q1 2020 | $3,000 | -25.0% | 68 | 0.0% | 0.00% | – |
Q4 2019 | $4,000 | -33.3% | 68 | -10.5% | 0.00% | – |
Q3 2019 | $6,000 | 0.0% | 76 | 0.0% | 0.00% | – |
Q2 2019 | $6,000 | +20.0% | 76 | +18.8% | 0.00% | – |
Q1 2019 | $5,000 | +66.7% | 64 | 0.0% | 0.00% | – |
Q4 2018 | $3,000 | -25.0% | 64 | 0.0% | 0.00% | – |
Q3 2018 | $4,000 | 0.0% | 64 | 0.0% | 0.00% | – |
Q2 2018 | $4,000 | 0.0% | 64 | 0.0% | 0.00% | – |
Q1 2018 | $4,000 | – | 64 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 367,754 | $10,911,000 | 4.08% |
AIGH Capital Management LLC | 244,500 | $7,254,000 | 1.91% |
Parkman Healthcare Partners LLC | 108,559 | $3,221,000 | 1.19% |
Worth Venture Partners, LLC | 60,831 | $1,927,000 | 1.13% |
Global Alpha Capital Management Ltd. | 323,731 | $9,605,000 | 1.04% |
Mesirow Financial Investment Management, Inc. | 6,892 | $204,000 | 0.99% |
MARATHON CAPITAL MANAGEMENT | 74,460 | $2,209,000 | 0.71% |
EMERALD ADVISERS, LLC | 455,880 | $13,526,000 | 0.70% |
EMERALD MUTUAL FUND ADVISERS TRUST | 356,865 | $10,588,000 | 0.61% |
Jackson Creek Investment Advisors LLC | 32,698 | $1,120,000 | 0.45% |